期刊文献+

Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism 被引量:16

在线阅读 下载PDF
导出
摘要 BACKGROUND The most effective treatment for advanced cirrhosis and portal hypertension is liver transplantation(LT).However,splenomegaly and hypersplenism can persist even after LT in patients with massive splenomegaly.AIM To examine the feasibility of performing partial splenectomy during LT in patients with advanced cirrhosis combined with severe splenomegaly and hypersplenism.METHODS Between October 2015 and February 2019,762 orthotopic LTs were performed for patients with end-stage liver diseases in Tianjin First Center Hospital.Eighty-four cases had advanced cirrhosis combined with severe splenomegaly and hypersplenism.Among these patients,41 received partial splenectomy during LT(PSLT group),and 43 received only LT(LT group).Patient characteristics,intraoperative parameters,and postoperative outcomes were retrospectively analyzed and compared between the two groups.RESULTS The incidence of postoperative hypersplenism(2/41,4.8%)and recurrent ascites(1/41,2.4%)in the PSLT group was significantly lower than that in the LT group(22/43,51.2%;8/43,18.6%,respectively).Seventeen patients(17/43,39.5%)in the LT group required two-stage splenic embolization,and further splenectomy was required in 6 of them.The operation time and intraoperative blood loss in the PSLT group(8.6±1.3 h;640.8±347.3 mL)were relatively increased compared with the LT group(6.8±0.9 h;349.4±116.1 mL).The incidence of postoperative bleeding,pulmonary infection,thrombosis and splenic arterial steal syndrome in the PSLT group was not different to that in the LT group,respectively.CONCLUSION Simultaneous PSLT is an effective treatment and should be performed in patients with advanced cirrhosis combined with severe splenomegaly and hypersplenism to prevent postoperative persistent hypersplenism.
出处 《World Journal of Gastroenterology》 SCIE CAS 2021年第7期654-665,共12页 世界胃肠病学杂志(英文版)
基金 National Natural Science Foundation of China,No.81870444 Tianjin Natural Science Foundation,No.19JCQNJC10300 Spring Bud Plan of Tianjin First Central Hospital,No.TFCHCL201801.
  • 相关文献

参考文献3

二级参考文献63

  • 1Yun-Fu Lu,Xin-Qiu Li,Xiao-Yu Han,Xiao-Guang Gong,Shun-Wu Chang.Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism[J].Asian Pacific Journal of Tropical Medicine,2013,6(8):663-666. 被引量:13
  • 2Kiszka-Kanowitz M, Henriksen JH, M-ller S, Bendtsen F. Bloodvolume distribution in patients with cirrhosis: aspects of the dualheadgamma-camera technique. J Hepatol 2001; 35: 605-612[PMID: 11690706 DOI: 10.1016/S0168-8278(01)00175-1].
  • 3Ozier Y, Klinck JR. Anesthetic management of hepatictransplantation. Curr Opin Anaesthesiol 2008; 21: 391-400 [PMID:18458561 DOI: 10.1097/ACO.0b013e3282ff85f4].
  • 4Henriksen JH. Volume adaptation in chronic liver disease: onthe static and dynamic location of water, salt, protein and red cellsin cirrhosis. Scand J Clin Lab Invest 2004; 64: 523-533 [PMID:15370457 DOI: 10.1080/00365510410002788].
  • 5Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B,Lebrec D. Total effective vascular compliance in patients withcirrhosis: a study of the response to acute blood volume expansion.Hepatology 1992; 15: 809-815 [PMID: 1568722].
  • 6Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A.Effect of low central venous pressure and phlebotomy on bloodproduct transfusion requirements during liver transplantations.Liver Transpl 2006; 12: 117-123 [PMID: 16382461 DOI: 10.1002/lt.20559].
  • 7Schroeder RA, Collins BH, Tuttle-Newhall E, Robertson K,Plotkin J, Johnson LB, Kuo PC. Intraoperative fluid managementduring orthotopic liver transplantation. J Cardiothorac VascAnesth 2004; 18: 438-441 [PMID: 15365923 DOI: 10.1053/j.jvca.2004.05.020].
  • 8Richardson PD. Physiological regulation of the hepaticcirculation. Fed Proc 1982; 41: 2111-2116 [PMID: 6804268].
  • 9Ito M, Maruhashi M, Sakai N, Mizoue K, Hanada K. NG-011 andNG-012, novel potentiators of nerve growth factor. I. Taxonomy,isolation, and physico-chemical and biological properties. JAntibiot (Tokyo) 1992; 45: 1559-1565 [PMID: 1473982].
  • 10Bennett TD, MacAnespie CL, Rothe CF. Active hepaticcapacitance responses to neural and humoral stimuli in dogs. Am JPhysiol 1982; 242: H1000-H1009 [PMID: 7091340].

共引文献27

同被引文献153

引证文献16

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部